菜宝钱包(caibao.it)是使用TRC-20协议的Usdt第三方支付平台,Usdt收款平台、Usdt自动充提平台、usdt跑分平台。免费提供入金通道、Usdt钱包支付接口、Usdt自动充值接口、Usdt无需实名寄售回收。菜宝Usdt钱包一键生成Usdt钱包、一键调用API接口、一键无实名出售Usdt。

首页社会正文

登1登2登3代理(www.99cx.vip):Jump in net profit, revenue for Supercomnet

admin2022-08-268

登1登2登3代理www.99cx.vip)实时更新发布最新最快最有效的登1登2登3代理网址,包括新2登1登2登3代理手机网址,新2登1登2登3代理备用网址,皇冠登1登2登3代理最新网址,新2登1登2登3代理足球网址,新2网址大全。

KUALA LUMPUR: Supercomnet Technologies Bhd’s (Scomnet) net profit surged 73.8% to RM9.4mil, or 1.23 sen earnings per share in the second quarter ended June 30 (2Q), compared with RM5.4mil, or 0.75 sen a year ago.

The medical devices manufacturer attributed the higher earnings to improved efficiencies, which resulted in better sales of higher margin products, namely in its medical segment. It was further helped by a favourable foreign exchange rate.

Its revenue for the quarter rose 21.71% to RM39.86mil against RM32.75mil posted in the previous corresponding period, driven by higher demand from the automotive, medical and industrial segments.

The group also saw its net profit margin grow from 16.51% in the last corresponding period to 23.59% in 2Q.

“We are in a situation now where we are working hard to meet the demand of our clients, both for the medical and automotive segment.

,

皇冠足球信用平台出租www.hg108.vip)是皇冠(正网)接入菜宝钱包的TRC20-USDT支付系统,为皇冠代理提供专业的网上运营管理系统。系统实现注册、充值、提现、客服等全自动化功能。采用的USDT匿名支付、阅后即焚的IM客服系统,让皇冠代理的运营更轻松更安全。

,

“While the medical segment is our key contributor profit-wise, we are also seeing a lot of demand and orders from the automotive segment. In the coming quarters, we expect revenue from the automotive segment to catch up to the medical segment level gradually.

“Profit will still largely continue to come from the medical segment,” managing director James Shiue said in a statement.

For the first six months, Scoment's net profit surged 62.3% to RM16.8mil from RM10.3mil previously while revenue expanded 7.84% from RM70.32mil to RM75.83mil.

“We remain optimistic about the group's mid-to long-term prospects underpinned by continuous growing customer demand, very visible orders at hand and several new products in the pipeline.

“In the remaining quarters of FY22, we expect one of our new medical products to start contributing to our revenue, after a very long wait,” Shiue said.


转载说明:本文转载自Sunbet。

网友评论